Hikma Pharmaceuticals buy BNP Paribas
Start price
14.05.25
/
50%
€23.40
Target price
14.05.26
-
Performance (%)
-23.50%
Price
16.01.26
€18.20
Summary
This prediction is currently active. The price of Hikma Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -23.50%. This prediction currently runs until 14.05.26. The prediction end date can be changed by BNP_Paribas at any time. BNP_Paribas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hikma Pharmaceuticals | 0.000% | 0.000% |
| iShares Core DAX® | 0.191% | 4.771% |
| iShares Nasdaq 100 | -0.614% | 3.137% |
| iShares Nikkei 225® | 0.599% | 8.016% |
| iShares S&P 500 | -0.036% | 3.593% |
Comments by BNP_Paribas for this prediction
In the thread Hikma Pharmaceuticals diskutieren
Hikma Pharmaceuticals PLC (OTCMKTS: HKMPF) is now covered by analysts at BNP Paribas. They set an "outperform" rating on the stock.
Ratings data for HKMPF provided by MarketBeat